Clinical trials
Active, not recruiting Phase 1 Glioma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 5 |
| 2023 | 8 |
| 2024 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 39 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| City of Hope Medical Center | 4 |
| National Cancer Institute (NCI) | 4 |
| Cellectar Biosciences, Inc. | 2 |
| Nader Sanai | 2 |
| Pfizer | 2 |
| Sabine Mueller, MD, PhD | 2 |
| Beijing Tiantan Hospital | 1 |
| Dana-Farber Cancer Institute | 1 |
| Daniel Landi | 1 |
| David W. Roberts | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioma | 39 |
| Glioblastoma | 22 |
| Brain Neoplasms | 12 |
| Astrocytoma | 8 |
| Medulloblastoma | 7 |
| Ependymoma | 6 |
| Oligodendroglioma | 6 |
| Diffuse Intrinsic Pontine Glioma | 5 |
| Central Nervous System Neoplasms | 4 |
| Gliosarcoma | 4 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.